Drugs / UroNext
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05945667 | Jun → Dec 2021 | cystitis | PharmaLinea Ltd. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2024-02-12 | NPO Petrovax | Results International journal publishes study exploring Uronext® properties to protect urinary tract petrovax.com ↗
The study showed positive findings: female patients in the Uronext ® group significantly less often experienced recurrent cystitis and reported an improved quality of life as compared to the control group. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2024-02-12 | NPO Petrovax | International journal publishes study exploring Uronext® properties to protect urinary tract petrovax.com ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UroNext | “Dietary Supplement: UroNext” NCT05945667 ↗ |